I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 27% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 27% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 52% | 914.93 | 1372 / 2642 | 40% | 4.41 | 283 / 705 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.01 | 1 / 230 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0.08 | 2 / 504 |
| stomach | 0% | 0 | 0 / 359 | 0% | 0.00 | 1 / 286 |
| lung | 0% | 0 | 0 / 578 | 0% | 0.07 | 4 / 1155 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 1 / 502 |
| breast | 0% | 0 | 0 / 459 | 0% | 0.00 | 1 / 1118 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| intestine | 0% | 0 | 0 / 966 | 0% | 0 | 0 / 527 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| skin | 0% | 0 | 0 / 1809 | 0% | 0 | 0 / 472 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| uterus | 0% | 0 | 0 / 170 | 0% | 0 | 0 / 459 |
| GO_0007423 | Biological process | sensory organ development |
| GO_0021542 | Biological process | dentate gyrus development |
| GO_0061564 | Biological process | axon development |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0070888 | Molecular function | E-box binding |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | NEUROD6 |
| Protein name | Neurogenic differentiation factor 6 (NeuroD6) (Class A basic helix-loop-helix protein 2) (bHLHa2) (Protein atonal homolog 2) Neurogenic differentiation factor |
| Synonyms | ATOH2 BHLHA2 My051 tcag7.685 |
| Description | FUNCTION: Activates E box-dependent transcription in collaboration with TCF3/E47. May be a trans-acting factor involved in the development and maintenance of the mammalian nervous system. Transactivates the promoter of its own gene (By similarity). . |
| Accessions | Q96NK8 A0A090N7T3 ENST00000297142.4 Q8IYR9 |
